Access Bio, Inc.

950130· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩2,255-2.80%

2026-08-21

Financials

Valuation Metrics

Access Bio, Inc.'s Market Cap is ₩793B. At end of 2025 it was ₩1337B. Ranked #1407 of 2,427 in KR market (top 58%), #792 of 1,645 on KOSDAQ (top 48%), #152 of 233 in Pharmaceuticals, Biotechnology & Life Sciences (top 65%) by Market Cap.

Investment Metrics(as of 2026-08-22)

Metric	Value	Rank
Size
Market Cap	79.32B KRW	KR#1,407/2,427 Sec#152/233
Revenue	23.82B KRW	KR—/2,427 Sec—/233
Net Income	-114.23B KRW	KR—/2,427 Sec—/233
Total Assets	631.40B KRW	KR—/2,427 Sec—/233
Net Assets	550.01B KRW	KR—/2,427 Sec—/233
Value
P/B	0.14x	KR#47/2,427 Sec#3/233
P/S	3.33x	KR#2,059/2,427 Sec#130/233
Profitability
ROE	-20.77%	KR—/2,427 Sec—/233
ROA	-18.09%	KR—/2,427 Sec—/233
Op. Margin	-308.42%	KR—/2,427 Sec—/233
Revenue Growth	-71.24%	KR—/2,427 Sec—/233
Financial Health
Debt Ratio	14.80%	KR—/2,427 Sec—/233
Total Debt	88.11B KRW	KR—/2,427 Sec—/233
Cash	237.77B KRW	KR—/2,427 Sec—/233
Current Ratio	16.86x	KR—/2,427 Sec—/233
Performance
1Y Return	-49.89%	KR#2,081/2,427 Sec#196/233
1M Return	0.67%	KR#1,501/2,427 Sec#156/233
From 52W High	-57.29%	KR#1,637/2,427 Sec#132/233
1Y MDD	-59.84%	KR#1,404/2,427 Sec#111/233
Trading
Volume	37,780 shares	KR#1,486/2,427 Sec#153/233
Trading Value	84.4M KRW	KR#1,823/2,427 Sec#189/233
Foreign Own.	4.75%	KR—/2,427 Sec—/233
Per Share
EPS	-3,248 KRW	KR—/2,427 Sec—/233
BPS	15,637 KRW	KR#670/2,427 Sec#44/233